MP 139 MS - agilent.com
4
ASMS 2014 MP 139 Sequence Variant Analysis of Therapeutic Proteins Using LC/MS/ MS Ning Tang, Agilent Technologies, Santa Clara, CA Page 1
Transcript of MP 139 MS - agilent.com
ASMS 2014
MP 139
Sequence Variant Analysis of Therapeutic Proteins Using LC/MS/MS
Ning Tang, Agilent Technologies, Santa Clara, CA
Page 1
Sequence Variant Analysis of Therapeutic Proteins Using LC/MS/MS
Page 2
Sequence Variant Analysis of Therapeutic Proteins Using LC/MS/MS
Page 3
Sequence Variant Analysis of Therapeutic Proteins Using LC/MS/MS
Page 4
![· PDF fileMP Marker. -'MP Marker: MP Marker: $4 MP M 03 MP arker: 32 MP 57 P MP MP Marker: 52 MP,M tk M arker:.4 payark MP Market] 45' 44, MP 42 MP Markeižøål](https://static.fdocuments.net/doc/165x107/5a8426c67f8b9ac96a8b63a3/marker-mp-marker-mp-marker-4-mp-m-03-mp-arker-32-mp-57-p-mp-mp-marker-52.jpg)
